Bio-Rad has entered a binding offer to purchase all equity interests in French biotech Stilla Technologies. According to ...
As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback